Valuation: Highnoon Laboratories Limited

Market Cap 50.93B 183M 161M 150M 137M 258M 17.66B 262M 1.78B 695M 8.68B 688M 674M 30.02B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 50.93B 183M 161M 150M 137M 258M 17.66B 262M 1.78B 695M 8.68B 688M 674M 30.02B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.49x
Free-Float
50.02%
Yield 2026 *
4.68%
Yield 2027 * 5.41%
1 day-0.45%
1 week-1.93%
Current month-4.14%
1 month-3.68%
3 months+0.60%
6 months-6.75%
Current year-5.99%
1 week 954.5
Extreme 954.5
999.9
1 month 921
Extreme 921
1,075
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.8558
1,241
Manager TitleAgeSince
Chief Executive Officer - 31/03/2015
Chief Executive Officer 63 31/12/1995
Director of Finance/CFO - 31/03/2020
Director TitleAgeSince
Chairman - 06/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%-1.93%-9.99%+160.84% 183M
+0.86%+1.43%+47.17%+161.40% 1,067B
+1.59%+4.09%+56.51%+52.79% 635B
+0.95%+1.91%+36.30%+83.13% 458B
+1.60%+6.25%+37.00%+30.00% 347B
-0.60%+1.52%+36.67%+39.80% 295B
-0.14%+0.60%+17.29%+18.19% 262B
+0.09%-2.82%-29.09%-41.29% 216B
+1.22%+2.66%+22.66%+59.81% 203B
-1.18%-3.70%+11.28%+67.43% 161B
Average +0.39%+0.92%+22.58%+63.21% 364.37B
Weighted average by Cap. +0.76%+1.95%+35.99%+78.15%

Financials

2026 *2027 *
Net sales 30.4B 109M 96.15M 89.41M 82.05M 154M 10.54B 157M 1.06B 415M 5.18B 411M 402M 17.92B 34.16B 123M 108M 100M 92.21M 173M 11.85B 176M 1.19B 466M 5.82B 462M 452M 20.14B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
24/07/26 PKR 961.21 -0.45% 10,530
23/07/26 PKR 965.57 -2.06% 17,377
22/07/26 PKR 985.90 -0.26% 7,936
21/07/26 PKR 988.49 -0.01% 17,909
20/07/26 PKR 988.58 +0.86% 13,499
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
961.21PKR
Average target price
1,121.00PKR
Spread / Average Target
+16.62%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock